By ...

12 de June de 2019

Brazilian regulatory agency (ANVISA) inaugurates discussion on cannabis for medicinal and scientific purposes

ANVISA’s Board of Directors approved the proposal to open two Public Consultations to regulate:

(i) the cultivation of the cannabis spp. for medical and scientific purposes; and

(ii) a specific procedure for registration and monitoring of medicines based on Cannabis spp., its derivatives, and synthetic analogs.

For further information, click below to access our full newsletter.

See file

Back

Last by ...

30 de September de 2026

NFL in Brazil: Kasznar Leonardos Supports Brand Protection at Historic Rio Game

The NFL made history in Brazil once again this weekend, bringing its first regular-season game to Rio de Janeiro and one of … NFL in Brazil: Kasznar Leonardos Supports Brand Protection at Historic Rio Game

4 de September de 2026

CONAR Tightens Betting Advertising Rules: New Restrictions on Influencers and Stronger Protections for Minors

On August 27, 2026, the National Council for Advertising Self-Regulation (CONAR) approved, significant updates to the Annex “X” of the Brazilian Advertising … CONAR Tightens Betting Advertising Rules: New Restrictions on Influencers and Stronger Protections for Minors

17 de July de 2026

New rules for “bets” in Brazil

In the context of the ongoing development of the regulated market, the legal framework governing fixed-odds betting (“bets”) has undergone significant updates … New rules for “bets” in Brazil